US rolls out plan to curb overuse of psychiatric medications

The Biden administration’s HHS, led by RFK Jr., announced a plan to reduce overprescribing of psychiatric medications, promote deprescribing and nonmedication treatments, and emphasize informed consent and shared decision-making, while coordinating across agencies to evaluate prescribing patterns and expand research and access—though experts warn against oversimplifying overmedicalization and note ongoing mental-health care access gaps.